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A B S T R A C T
There have been rare case series with familial clustering of peripartum cardiomyopathy (PPCMP). Due to
the concomitant occurrence of PPCMP and idiopathic dilated cardiomyopathy, it has been suggested that
genetics might play a role in the pathogenesis of PPCMP. Herein, we report four cases of PPCMP in the
same family, who showed full recovery of left ventricular function within a short period.
<Learning objective: Physicians caring for peripartum cardiomyopathy (PPCMP) patients should be
aware that PPCMP may have a genetic background and guidelines for diagnosis of genetic cardiomyopathy
should be considered.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Peripartum cardiomyopathy (PPCMP) is deﬁned by the Heart
Failure Association of the European Society of Cardiology as ‘an
idiopathic cardiomyopathy presenting with heart failure secondary
to left ventricular (LV) systolic dysfunction towards the end of
pregnancy or in the months following delivery, where no
determinable cause of heart failure is found. The LV may not be
dilated but the ejection fraction (EF) is nearly always reduced below
45%’ [1]. The exact pathophysiology of PPCMP is unclear, and many
potential causes have been proposed including genetics [2]. The
frequency of mutations associated with familial dilated cardiomy-
opathy genes in patients with PPCMP suggests that there may be an
overlap in the clinical spectrum of these two conditions [3,4]. A
genetic basis for PPCMP is controversial, while some case reports
noted familial inclination [5–7], as well as other large case series did
not report family history as a PPCMP risk factor [8]. Herein, we
present the case of two sisters from common parents with the
diagnosis of PPCMP, who have fully recovered within 6 months.
PPCMP was further diagnosed in two maternal cousins after a
detailed family screening.
Case report
Two Caucasian sisters (both from common parents) with a
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and experienced singleton pregnancy without any obstetrical
complications. The ﬁrst was diagnosed with PPCMP just after
3 months of the ﬁrst labor at the age of 27 years. She had undergone
normal spontaneous vaginal delivery at the 38th week of gestation.
She had no systemic/cardiovascular disease, smoking history,
medication, or PPCMP-associated risk factors. Her electrocardiogra-
phy (ECG) showed sinus rhythm (72 bpm) with QRS duration of
120 ms. Her transthoracic echocardiography revealed a LVEF of 30%,
LV end-diastolic diameter (LVEDD) of 60 mm and global LV
hypokinesia. Although she had New York Heart Association (NYHA)
class III symptoms at the time of diagnosis, she rapidly recovered in a
6-month period with medical therapy including ramipril, carvedilol,
and digoxin. At 3rd year follow-up visit, she was asymptomatic with
a LVEF of 58%, LVEDD of 52 mm, and on no medication. In the second
sister, PPCMP was diagnosed at the 5th month of puerperium (ﬁrst
birth) at age 29 years. She had undergone normal spontaneous
vaginal delivery at 37th week of gestation. She also had no systemic/
cardiovascular disease, smoking history, medication or PPCMP-
associated risk factors including obesity. Her ECG showed sinus
rhythm (64 bpm) with QRS duration of 100 ms. Her transthoracic
echocardiography revealed a LVEF of 40%, LVEDD of 56 mm, and
global LV hypokinesia. At the time of diagnosis, she had NYHA class
III symptoms and again recovered in an 8-month period with
medical therapy including ramipril and carvedilol. At 2nd year
follow-up visit, she was asymptomatic with a LVEF of 64%, LVEDD of
50 mm, and on no medical therapy. Because of such a clustering of
PPCMP in this family, we screened the available 15 family members
including their ﬁrst-degree (parents, male sibling) and second-
degree relatives with echocardiography. There was no pathological reserved.
Fig. 1. Schematic of family pedigree of the patients affected by peripartum cardiomyopathy.
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myocardial infarction. Also 3rd and 4th generation family history
assessment revealed that 2 cousins (maternal) had PPCMP history
similarly (diagnosed after birth and recovered in a 6-month period)
(Fig. 1). However, the patients and family members refused to
participate in a genetic testing, so, we could not gain any data
regarding the common genetic mutations among them.
Discussion
PPCMP is a rarely seen idiopathic cardiomyopathy that affects
women toward the end of pregnancy or in the months following
delivery with unclear pathophysiological basis. Although approxi-
mately 50% of the patients recover, the clinical course is
unpredictable and some patients develop refractory heart failure
and persistent LV systolic dysfunction [1,9]. Although the exact
etiology of PPCMP is unclear, different mechanisms are probable
including genetics [2]. In small sample size studies, it has been
shown for the ﬁrst time that there might be a familial and genetic
predisposition for PPCMP, activated during mid to late pregnancy
[3,4]. However, a genetic basis for PPCMP has not been
systematically studied. Also there may be a fact that some forms
of familial PPCMP could be an unknown familial dilated
cardiomyopathy unmasked by pregnancy. Herein, we presented
the case of 2 sisters in the same family who developed PPCMP
without any PPCMP-associated and other risk factors. Also a
similar clinical scenario has been found in their 3rd generation
family members. So, clustering of such a clinical ﬁnding cannot be
explained by chance and also recovery of the disease in all those
family members made us thought to exclude overlapping of PPCMPwith familial dilated cardiomyopathy. In accordance with the
suggestions of Morales et al. [4], we remind that physicians caring
for PPCMP patients should be aware that PPCMP may have a
genetic background and guidelines for diagnosis of genetic
cardiomyopathy should be considered. Particularly, such an
evaluation may include clinical screening (family history, medical
history, ECG, echocardiography) of the patient and her/his ﬁrst-
degree relatives. Also, genetic counseling, including reproductive
risk counseling about PPCMP, is recommended, in addition to
consideration of genetic testing.
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